The race against virus variants
Newsletter Edition #29 [The Weekly Primer]
Hi,
The variants of SARS-CoV-2 have upended not only assumptions of epidemiologists but also of investment managers.
Coming weeks will show how governments and health authorities will cope with the mutating virus and how this will actively shape research and investment efforts for COVID-19 medical products. If you want to share your perspectives on this,…
Keep reading with a 7-day free trial
Subscribe to Geneva Health Files to keep reading this post and get 7 days of free access to the full post archives.